• Read the Report
  • Contact Us
Menu
  • Background
    • HIV and the Law
    • Commission Overview
    • Commissioners
    • Technical Advisory Group
  • Dialogues
    • Global Dialogue 2018
      • 2018 Supplement
      • Global Dialogue 2018 Videos
    • Global Dialogue 2012
      • Video
      • Photo Gallery
      • Speeches
    • Regional Dialogues
      • Asia-Pacific Regional Dialogue
      • Caribbean
      • Eastern Europe and Central Asia
      • Latin America
      • Africa
      • Middle East and North Africa
      • High Income Countries
      • Civil Society Participation
      • Submissions to the Regional Dialogues
  • Implementation
    • Programmes
      • Being LGBTI in Asia
      • Challenging stigma and discrimination in the Caribbean
      • Improving SRHR for young key populations in Southern Africa
      • Multi-Country Western Pacific Integrated HIV/TB Project
      • Promoting a rights-based response to HIV in Africa
      • Removing legal barriers in Africa
      • South Asia Global Fund HIV Programme
      • UHC Legal Solutions Network
    • Follow Up
      • Follow Up Stories
      • Legal Environment Assessments
      • Leave No One Behind: Lessons from the Global Commission on HIV and the Law for Agenda 2030
  • Resources
    • International Guidelines on Human Rights & Drug Policy
    • eLibrary
      • Capacity Development Toolkits
      • Fact Sheets
      • Legal Environment Assessments, Reviews and Audits
      • National Dialogue Reports
      • Policy and Issue Briefs
      • Research, Discussion Papers and Reports
    • Report Resources
      • Read the Report
      • 2018 Supplement
      • Working Papers
      • Submissions
      • Presentations
      • Articles and Speeches from Commissioners
      • Selected Bibliographies
    • Regional Dialogue Resources
      • Asia-Pacific
      • Caribbean
      • Latin America
      • Eastern Europe and Central Asia
      • Africa
      • High Income Countries
  • News
    • News Articles
    • Press Releases
    • Newsletter Archives
  • Past Events
News

UNAIDS and UNDP back proposal to allow least-developed countries to maintain and scale up access to essential medicines

By katemcqdev

26/02/2013

UNAIDS and UNDP back proposal to allow least-developed countries to maintain and scale up access to essential medicines

Published on Tuesday, 26 February 2013 09:17
Press release Failure to extend the transition period for least-developed countries to become fully compliant with the TRIPS Agreement could put millions of lives at risk

GENEVA, 26 February 2013—The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the United Nations Development Programme (UNDP) today launched a new Issue Brief TRIPS transition period extensions for least-developed countries. The Issue Brief outlines that failure to extend the transition period for least-developed countries to become fully compliant with the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) could seriously impede access to lifesaving antiretroviral treatment and other essential medicines for people most in need.

Least-developed countries (LDCs) are home to some of the world’s most vulnerable people and bear considerable health burdens. In 2011, some 9.7 million of the 34 million people living with HIV worldwide, lived in LDCs. Of the people living with HIV in LDCs, 4.6 million were eligible for antiretroviral treatment in accordance with the 2010 World Health Organization HIV treatment guidelines, however only 2.5 million were receiving it.

In the 49 countries which are considered LDCs by the United Nations, non-communicable disease burdens are also rising much faster than in higher income countries. Data from low-income countries for instance suggests that cancer incidence is expected to rise by 82% from 2008 to 2030, whereas in high-income countries incidence is expected to rise at the much lower rate of 40%, in part due to widespread access to vaccines and medicines.

“Access to affordable HIV treatment and other essential medicines is vital if least-developed countries are to achieve the health-related and other Millennium Development Goals”, said Helen Clark, UNDP Administrator. In the Issue Brief, UNAIDS and UNDP urge WTO Members to give urgent consideration to the continued special needs and requirements of LDCs in respect of their social and economic development. “An extension would allow the world’s poorest nations to ensure sustained access to medicines, build up viable technology bases and manufacture or import the medicines they need,” said Michel Sidibé, Executive Director of UNAIDS. The TRIPS Agreement was introduced in 1995 as a means of protecting intellectual property rights on a global scale.

Patent protection, however, has also proved to be one of the factors contributing to high costs of medicines, placing many essential treatments outside the reach of LDCs. In recognition of this, WTO Members retained important options and flexibilities in the TRIPS Agreement. One of the flexibilities was that LDCs were granted an initial ten year transition period to become TRIPS compliant. Two extensions to this time period were granted.

The general exception is due to expire on 31 July 2013. A proposal currently before the TRIPS Council, submitted on behalf of LDCs, requests a further extension to the general exemption from full TRIPS compliance for as long as a country remains an LDC. The proposal is due to be discussed at the 5-6 March meeting of the TRIPS Council in Geneva, Switzerland.

In the lead-up to and during discussions, UNAIDS and UNDP encourage all WTO Members to consider the full range of possible public health, economic and development benefits of such an extension.  

Source: UNAIDS

Share this:

  • Twitter
  • Facebook

Recent Posts

  • People living with HIV in Kyrgyzstan have won the right to adopt
  • Legal and Policy Trends Impacting People Living with HIV and Key Populations in Asia and the Pacific 2014-2019
  • UNAIDS update: COVID-19 should not be a reason to delay 2030 deadline to end AIDS as a public health threat
  • 2020 Global HIV Policy Report: Policy Barriers to HIV Progress
  • UNAIDS hails new results showing that long-acting injectable medicines are highly effective in preventing HIV among women

© 2017 [blog-link], All Rights Reserved.